Innovative Eyewear, Inc. (LUCY)
USD 1.79
(-3.76%)
USD 1.79
(-3.76%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -4.28 Million USD | -21.47% |
| 2022 | -3.52 Million USD | -1786.44% |
| 2021 | 209.3 Thousand USD | -63.44% |
| 2020 | 572.51 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -5.89 Million USD | -122.64% |
| 2024 Q1 | -2.64 Million USD | 38.23% |
| 2023 FY | -4.28 Million USD | -21.47% |
| 2023 Q2 | -5.35 Million USD | -55.27% |
| 2023 Q1 | -3.44 Million USD | 2.26% |
| 2023 Q4 | -4.28 Million USD | -9.83% |
| 2023 Q3 | -3.9 Million USD | 27.12% |
| 2022 Q2 | 1.9 Million USD | 57.05% |
| 2022 Q1 | 1.21 Million USD | 478.9% |
| 2022 FY | -3.52 Million USD | -1786.44% |
| 2022 Q4 | -3.52 Million USD | 26.62% |
| 2022 Q3 | -4.81 Million USD | -352.77% |
| 2021 Q2 | 73.99 Thousand USD | 173.84% |
| 2021 FY | 209.3 Thousand USD | -63.44% |
| 2021 Q1 | 27.02 Thousand USD | -95.28% |
| 2021 Q4 | 209.3 Thousand USD | -41.05% |
| 2021 Q3 | 355.04 Thousand USD | 379.8% |
| 2020 Q4 | 572.51 Thousand USD | 0.0% |
| 2020 FY | 572.51 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 266.116% |
| AngioDynamics, Inc. | -70.14 Million USD | 93.887% |
| AtriCure, Inc. | -9.81 Million USD | 56.322% |
| Avinger, Inc. | 10.12 Million USD | 142.366% |
| Azenta, Inc. | -618.47 Million USD | 99.307% |
| BioLife Solutions, Inc. | 7.25 Million USD | 159.113% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.175% |
| Daxor Corporation | 755.65 Thousand USD | 667.379% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -191.663% |
| Femasys Inc. | -15.01 Million USD | 71.446% |
| GlucoTrack, Inc. | -4.29 Million USD | 0.199% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 111.139% |
| Hologic, Inc. | 374.4 Million USD | 101.145% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.296% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.839% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 39.074% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 17.135% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -0.0% |
| Masimo Corporation | 804 Million USD | 100.533% |
| Microbot Medical Inc. | -2.28 Million USD | -87.552% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 55.319% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 101.419% |
| Nephros, Inc. | -2.47 Million USD | -73.511% |
| NovoCure Limited | 355.42 Million USD | 101.206% |
| NEXGEL, Inc. | 98 Thousand USD | 4474.946% |
| NEXGEL, Inc. | 98 Thousand USD | 4474.946% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 107.26% |
| OraSure Technologies, Inc. | -276.9 Million USD | 98.452% |
| Pro-Dex, Inc. | 10.91 Million USD | 139.277% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 87.827% |
| Predictive Oncology Inc. | -5.87 Million USD | 26.983% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 241.538% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.172% |
| Repligen Corporation | -39.51 Million USD | 89.151% |
| Sanara MedTech Inc. | 6.64 Million USD | 164.522% |
| STAAR Surgical Company | -147.2 Million USD | 97.087% |
| Sharps Technology, Inc. | -3.01 Million USD | -42.303% |
| Utah Medical Products, Inc. | -92.52 Million USD | 95.366% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.218% |
| Jin Medical International Ltd. | -2.81 Million USD | -52.226% |